Familial defective apolipoprotein B-100: A mutation emerged in the Mesolithic ancestors of Celtic peoples?

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 433-436

  Miserez, Andreé R ^a   Muller, Patrick Y ^a  

^a University ORL Clinic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100;

CONFERENCE PAPER; EVOLUTION; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; MUTATION; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; EVOLUTION, MOLECULAR; HOMINIDAE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MUTATION; SWITZERLAND;

EID: 0033979465     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00470-0     Document Type: Article

References (30)

1. Burnand B., Wietlisbach V., Riesen W. et al. Lipides sanguins dans la population suisse: enquête MONICA 1988-89. Schweiz. Med. Wschr. 123(Suppl. 48):1993;29-37.
2. US Department of Health and Human Services, Lipid Research Clinics Program. Population Studies Data Book. Vol. I, The Prevalence Study. Washington DC: Public Health Service, National Institutes of Health (NIH 80-1527) 1980. p. 27-81.
3. Verschuren W.M.M., Jacobs D.R., Bloemberg B.P.M. et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study. J. Am. Med. Assoc. 274:1995;131-136.
4. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II), J Am Med Assoc 1993;269(23):3015-3023.
5. Miserez A.R., Schuster H., Chiodetti N., Keller U. Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. Am. J. Hum. Genet. 52:1993;808-826.
6. Miserez A.R., Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;1719-1729.
7. Conne B., Zufferey R., Belin D. The A985G mutation in the medium-chain acyl-CoA dehydrogenase gene: high prevalence in the Swiss population resident in Geneva. J. Inher. Metab. Dis. 18:1995;577-583.
8. Malik N.J., Morris M.A., Thonney F., Bühler E.M. A very frequent frameshift mutation of the cystic fibrosis gene in the Swiss population. Am. J. Hum. Genet. 53:1993;A1198.
9. Vega G.L., Grundy S.M. In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J. Clin. Invest. 78:1986;1410-1414.
10. Innerarity T.L., Weisgraber K.H., Arnold K.S. et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad. Sci. USA. 84:1987;6919-6923.
11. Weisgraber K.H., Innerarity T.L., Newhouse Y.M. et al. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Proc. Natl. Acad. Sci. USA. 85:1988;9758-9762.
12. Soria L.F., Ludwig E.H., Clarke H.R.G., Vega G.L., Grundy S.M., McCarthy B.J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. USA. 86:1989;587-591.
13. Myant N.B., Forbes S.A., Day I.N.M., Gallagher J. Estimation of the age of the ancestral arginine 3500-glutamine mutation in human Apo B-100. Genomics. 45:1997;78-87.
14. Gaffney D., Reid J.M., Cameron I.M. et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;1025-1029.
15. Pullinger C.R., Hennessy L.K., Chatterton J.E. et al. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J. Clin. Invest. 95:1995;1225-1234.
16. Innerarity T.L., Mahley R.W., Weisgraber K.H. et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J. Lipid. Res. 31:1990;1337-1349.
17. Schuster H., Rauh G., Kormann B. et al. Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich. Arteriosclerosis. 10:1990;577-581.
18. Tybjærg-Hansen A., Humphries S.E. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis. 96:1992;91-107.
19. Miserez A.R., Laager R., Chiodetti N., Keller U. High prevalence of familial defective apolipoprotein B-100 in Switzerland. J. Lipid. Res. 35:1994;574-583.
20. Brousseau T., Arveiler D., Cambou J.-P. et al. Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study (Letter). Atherosclerosis. 116:1995;269-271.
21. Corsini A., McCarthy B.J., Granata A. et al. Familial defective apo B-100, characterization of an Italian family. Eur. J. Clin. Invest. 21:1991;389-397.
22. Corsini A. Epidemiology of familial hypercholesterolemia in Italy, communicated at the European Workshop on LDL-receptor Defects, Munich, 2-5 December 1993 (unpublished).
23. Pimstone S.N., Defesche J.C., Clee S.M., Bakker H.D., Hayden M.R., Kastelein J.J.P. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17:1997;826-833.
24. März W., Ruzicka C., Pohl T., Usadel K.H., Gross W. Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient. Lancet. 340:1992;1362.
25. Rauh G., Keller C., Kormann B. et al. Familial defective apolipoprotein B-100: clinical characteristics of 54 cases. Atherosclerosis. 92:1992;233-241.
26. Le Tensorer J-M, Niffeler U. SPM I. Die Schweiz vom Palaeolithikum bis zum frühen Mittelalter. Basel, Verlag Schweizerische Gesellschaft für Ur- und Frühgeschichte 1993. p. 203-241.
27. Hämäläinen T., Palotie A., Aalto-Setälä K., Kontula K., Tikkanen M.J. Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol. Atherosclerosis. 82:1990;177-183.
28. Kimura M. Stochastic processes in population genetics with special reference to distribution of gene frequencies and probability of gene fixation. 1970;Springer, Berlin.
29. Nei M. Genetic relationship and evolution of human races. Evolutionary Biology. 1967;1-59 Plenum Press, New York.
30. Farese R.V., Ruland S.L., Flynn L.M., Stokowski R.P., Young S.G. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl. Acad. Sci. USA. 92:1995;1774-1778.